170 related articles for article (PubMed ID: 32979152)
1. Activation of autophagy following [HuArgI (Co)-PEG5000]-induced arginine deprivation mediates cell death in colon cancer cells.
Swayden M; Bekdash A; Fakhoury I; El-Atat O; Borjac-Natour J; El-Sibai M; Abi-Habib RJ
Hum Cell; 2021 Jan; 34(1):152-164. PubMed ID: 32979152
[TBL] [Abstract][Full Text] [Related]
2. Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells.
Khoury O; Ghazale N; Stone E; El-Sibai M; Frankel AE; Abi-Habib RJ
J Neurooncol; 2015 Mar; 122(1):75-85. PubMed ID: 25567351
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent.
Nasreddine G; El-Sibai M; Abi-Habib RJ
Invest New Drugs; 2020 Feb; 38(1):10-19. PubMed ID: 30887252
[TBL] [Abstract][Full Text] [Related]
4. [HuArgI (co)-PEG5000]-induced arginine deprivation leads to autophagy dependent cell death in pancreatic cancer cells.
Khalil N; Abi-Habib RJ
Invest New Drugs; 2020 Oct; 38(5):1236-1246. PubMed ID: 31823161
[TBL] [Abstract][Full Text] [Related]
5. Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells.
Tanios R; Bekdash A; Kassab E; Stone E; Georgiou G; Frankel AE; Abi-Habib RJ
Leuk Res; 2013 Nov; 37(11):1565-71. PubMed ID: 24018014
[TBL] [Abstract][Full Text] [Related]
6. Human Recombinant Arginase I [HuArgI (Co)-PEG5000]-Induced Arginine Depletion Inhibits Colorectal Cancer Cell Migration and Invasion.
Al-Koussa H; Al-Haddad M; Abi-Habib R; El-Sibai M
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795337
[TBL] [Abstract][Full Text] [Related]
7. Human Recombinant Arginase I [HuArgI(Co)-PEG5000]-Induced Arginine Depletion Inhibits Pancreatic Cancer Cell Migration and Invasion Through Autophagy.
El-Mais N; Fakhoury I; Al Haddad M; Nohra S; Abi-Habib R; El-Sibai M
Pancreas; 2021 Sep; 50(8):1187-1194. PubMed ID: 34714283
[TBL] [Abstract][Full Text] [Related]
8. Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA.
El-Mais N; Fakhoury I; Abdellatef S; Abi-Habib R; El-Sibai M
J Ovarian Res; 2021 Jan; 14(1):13. PubMed ID: 33423701
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells.
Agrawal V; Woo JH; Mauldin JP; Jo C; Stone EM; Georgiou G; Frankel AE
Anticancer Drugs; 2012 Jan; 23(1):51-64. PubMed ID: 21955999
[TBL] [Abstract][Full Text] [Related]
10. Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis.
Delage B; Luong P; Maharaj L; O'Riain C; Syed N; Crook T; Hatzimichael E; Papoudou-Bai A; Mitchell TJ; Whittaker SJ; Cerio R; Gribben J; Lemoine N; Bomalaski J; Li CF; Joel S; Fitzgibbon J; Chen LT; Szlosarek PW
Cell Death Dis; 2012 Jul; 3(7):e342. PubMed ID: 22764101
[TBL] [Abstract][Full Text] [Related]
11. TRAIL induces autophagic protein cleavage through caspase activation in melanoma cell lines under arginine deprivation.
You M; Savaraj N; Kuo MT; Wangpaichitr M; Varona-Santos J; Wu C; Nguyen DM; Feun L
Mol Cell Biochem; 2013 Feb; 374(1-2):181-90. PubMed ID: 23180246
[TBL] [Abstract][Full Text] [Related]
12. Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes.
Kuo MT; Savaraj N; Feun LG
Oncotarget; 2010 Aug; 1(4):246-51. PubMed ID: 21152246
[TBL] [Abstract][Full Text] [Related]
13. Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy.
Changou CA; Chen YR; Xing L; Yen Y; Chuang FY; Cheng RH; Bold RJ; Ann DK; Kung HJ
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14147-52. PubMed ID: 25122679
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes.
Alexandrou C; Al-Aqbi SS; Higgins JA; Boyle W; Karmokar A; Andreadi C; Luo JL; Moore DA; Viskaduraki M; Blades M; Murray GI; Howells LM; Thomas A; Brown K; Cheng PN; Rufini A
Sci Rep; 2018 Aug; 8(1):12096. PubMed ID: 30108309
[TBL] [Abstract][Full Text] [Related]
15. A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas.
Bean GR; Kremer JC; Prudner BC; Schenone AD; Yao JC; Schultze MB; Chen DY; Tanas MR; Adkins DR; Bomalaski J; Rubin BP; Michel LS; Van Tine BA
Cell Death Dis; 2016 Oct; 7(10):e2406. PubMed ID: 27735949
[TBL] [Abstract][Full Text] [Related]
16. Unlocking the Potential of Arginine Deprivation Therapy: Recent Breakthroughs and Promising Future for Cancer Treatment.
Chu YD; Lai MW; Yeh CT
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445845
[TBL] [Abstract][Full Text] [Related]
17. L-arginase from Streptomyces diastaticus MAM5 as a potential therapeutic agent in breast cancer: Purification, characterization, G1 phase arrest and autophagy induction.
Hassabo AA; Abdelraof M; Allam RM
Int J Biol Macromol; 2023 Jan; 224():634-645. PubMed ID: 36302487
[TBL] [Abstract][Full Text] [Related]
18. BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma.
Li YY; Wu C; Chen SM; Shah SS; Wangpaichitr M; Feun LG; Kuo MT; Suarez M; Prince J; Savaraj N
Oncotarget; 2016 Apr; 7(14):17665-80. PubMed ID: 26771234
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human arginase toxicity in mice is reduced by citrulline supplementation.
Mauldin JP; Zeinali I; Kleypas K; Woo JH; Blackwood RS; Jo CH; Stone EM; Georgiou G; Frankel AE
Transl Oncol; 2012 Feb; 5(1):26-31. PubMed ID: 22348173
[TBL] [Abstract][Full Text] [Related]
20. Deprivation of arginine by recombinant human arginase in prostate cancer cells.
Hsueh EC; Knebel SM; Lo WH; Leung YC; Cheng PN; Hsueh CT
J Hematol Oncol; 2012 Apr; 5():17. PubMed ID: 22546217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]